Caspase-1-4 Inhibitor VX-765 CAS: 273404-37-8 is a type of medication used to treat inflammatory diseases such as rheumatoid arthritis and cerebral ischemia. Its chemical name is (2S)-1-(2-(tert-butylamino)-2-oxoethyl)-N-((1r)-2-(4-(4-phenylpiperazin-1-yl)phenyl)-1-(pyridin-3-yl)ethyl)-2-oxopyrrolidine-3-carboxamide, and its molecular formula is C32H42N6O4. The formula weight is 570.72 g/mol, and its CAS number is 273404-37-8.
Top ten keywords from Google and Synonyms
Synonyms: VRT-043198, N-((1r)-2-(4-(4-phenylpiperazin-1-yl)phenyl)-1-(pyridin-3-yl)ethyl)-2-oxo-1-(2-(tert-butylamino)-2-oxoethyl)pyrrolidine-3-carboxamide
Health Benefits of Caspase-1-4 Inhibitor VX-765 Caspase-1-4 Inhibitor VX-765 is a promising medication for the treatment of inflammatory diseases such as rheumatoid arthritis and cerebral ischemia. It works by inhibiting certain enzymes called caspases, which are involved in the inflammatory response. By inhibiting these enzymes, VX-765 can reduce inflammation and protect against cell damage.
Potential Effects of VX-765 Studies have shown that VX-765 can reduce inflammation and protect against cell damage in a variety of conditions, including rheumatoid arthritis, cerebral ischemia, and neurodegenerative diseases. It may also have a protective effect on the brain by reducing the production of cancer-causing agents.
Product Mechanism VX-765 works by inhibiting the activity of caspases, which are enzymes involved in the inflammatory response. It inhibits caspase-1 and caspase-4, which are important regulators of inflammation in the body. By inhibiting these enzymes, VX-765 can reduce inflammation and protect against cell damage.
Safety and Side Effects As with any medication, there are potential side effects and risks associated with using VX-765. Common side effects of VX-765 include headache, nausea, and diarrhea. Other less common side effects can occur, including liver toxicity, skin rash, and allergic reactions.
Dosing Information The recommended dose of VX-765 varies depending on the specific condition being treated, the patient's health status, and other factors. Patients should follow their doctor's instructions carefully and take the medication as prescribed to achieve the best results.
Conclusion Caspase-1-4 Inhibitor VX-765 is a promising medication for the treatment of inflammatory diseases such as rheumatoid arthritis and cerebral ischemia. It works by inhibiting certain enzymes called caspases, which are involved in the inflammatory response. By inhibiting these enzymes, VX-765 can reduce inflammation and protect against cell damage. Patients who are considering using VX-765 should talk to their doctor about whether it is the right treatment option for them, and carefully weigh the benefits and risks. With proper medical supervision, VX-765 may offer hope for patients suffering from these debilitating diseases.
